Clinical study on the integrated program of postoperative health care for gastric cancer based on spleen as the foundation of acquired(part of randomized controlled trial)
- Conditions
- cancer
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Tumor patients with definite pathological and cytological diagnosis. (2) The syndrome type of TCM was diagnosed as spleen deficiency syndrome. (3) Patients aged from 18 to 80 years old, regardless of gender. (4) Karnofsky scores =70. (5) no serious diseases of the heart, liver, kidney, hematopoietic system or other factors affecting drug evaluation. (6) Those who can understand the situation of this experiment and have signed the informed consent. (7) Patients with nutritional risk were assessed as having nutritional status.
(1) Those who do not meet the inclusion criteria. (2) Patients with obvious damage of heart, liver, kidney or hematopoietic function, or mental patients, pregnant or lactating women. (3) Participants in other drug trials. (4) Those who are known to be allergic to this drug or do not take the drug as prescribed or have incomplete information.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method traditional Chinese medicine syndrome score;
- Secondary Outcome Measures
Name Time Method abdominal ultrasound scan;vascular endothelial growth factor;carcino-embryonic antigen;Carbohydrate Antigen 199;Carbohydrate Antigen 50;Quality of Life Core Scale;Karnofsky performance status;abdominal computerized tomography scan (CT) or magnetic resonance imaging (MRI);Carbohydrate Antigen 125;fibroenteroscope or barium enema;disease -free-survival;